Diagnosis and treatment of chronic myelomonocytic leukemia
Author:
Open Access
- 30 April 2021
- journal article
- review article
- Published by Springer Nature in Blood Research
- Vol. 56 (S1) , S5-S16
Abstract
Jihyun Kwon. Blood Res 2021;56:S5-S16. https://doi.org/10.5045/br.2021.2020321Keywords
This publication has 94 references indexed in Scilit:
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMMLLeukemia, 2013
- High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective studyLeukemia & Lymphoma, 2012
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3ABlood, 2011
- Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and ComorbiditiesTransplantation and Cellular Therapy, 2011
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsLeukemia, 2011
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2010
- Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experienceBone Marrow Transplantation, 2010
- Outcome of allo-SCT for chronic myelomonocytic leukemiaBone Marrow Transplantation, 2008
- Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemiaCancer, 2007
- Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaBone Marrow Transplantation, 2006